Liquid Ventilation

Subscribe to Selected New Research on Liquid Ventilation

220 relevant articles (40 outcomes, 43 trials/studies) found for this Therapy

Description: Artificial respiration (RESPIRATION, ARTIFICIAL) using an oxygenated fluid.

Also Known As:

Fluorocarbon Ventilation; Liquid Assisted Ventilation; Partial Liquid Ventilation; Assisted Ventilation, Liquid; Liquid Ventilation, Partial; Liquid Ventilation, Total; Ventilation, Fluorocarbon; Ventilation, Liquid; Ventilation, Liquid Assisted; Ventilation, Partial Liquid; Ventilation, Total Liquid; Total Liquid Ventilation

Relationship Network

Therapy Context: Research Results

Therapeutics: 5215

Respiratory Therapy: 481

Artificial Respiration: 7801

Liquid Ventilation: 220

Experts

1.	Hirschl, Ronald B: 4 articles (08/2006 - 01/2002)
2.	Davies, M W: 4 articles (01/2004 - 06/2001)
3.	Kaisers, U: 3 articles (12/2001 - 03/2001)
4.	Rossaint, R: 3 articles (03/2001 - 01/2000)
5.	Dembinski, R: 3 articles (03/2001 - 01/2000)
6.	Kuhlen, R: 3 articles (03/2001 - 01/2000)
7.	Max, M: 3 articles (03/2001 - 01/2000)
8.	Bartlett, Robert H: 2 articles (08/2006 - 03/2002)
9.	Wolfson, Marla R: 2 articles (04/2004 - 10/2002)
10.	Shaffer, Thomas H: 2 articles (04/2004 - 10/2002)

Related Diseases

1.	Adult Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/01/2004 - "Efficacy of partial liquid ventilation in improving acute lung injury induced by intratracheal acidified infant formula: determination of optimal dose and positive end-expiratory pressure level." 03/01/2006 - "Partial liquid ventilation may be beneficial in young patients with acute lung injury or ARDS, although further study is needed to confirm this." 10/01/2003 - "We sought to know whether there is a further improvement in gas exchange when partial liquid ventilation (PLV) is added to high-frequency oscillatory ventilation (HFOV) in a piglet model of saline lavage-induced acute lung injury" 08/01/2002 - "This prospective randomized pilot study aimed to test the hypotheses that partial liquid ventilation combined with a high positive end-expiratory pressure (PEEP) and a moderate tidal volume results in improved gas exchange and lung mechanics without negative hemodynamic influences compared with conventional mechanical ventilation in acute lung injury in piglets" 01/01/2002 - "Partial liquid ventilation (PLV) with various types of perfluorochemicals (PFC) has been shown to be beneficial in treating acute lung injury" Order ALL the reference details at left...
2.	Respiratory Insufficiency (Respiratory Failure) 02/01/1996 - "The ability of total liquid ventilation to enhance recruitment of atelectatic lung regions may be an important means by which gas exchange is improved during total liquid ventilation when compared with gas ventilation in the setting of respiratory failure." 11/01/1996 - "Liquid ventilation with perfluorocarbon has been effective in improving gas exchange and pulmonary function in the setting of acute respiratory failure" 10/01/1996 - "A number of studies have demonstrated the efficacy of perfluorocarbon liquid ventilation in improving gas exchange and pulmonary function in a number of animal species in the setting of acute respiratory failure" 07/01/1996 - "OBJECTIVE: To demonstrate the efficacy of partial perfluorocarbon liquid ventilation in large animal model of acute respiratory failure" 07/01/1996 - "Efficacy of perfluorocarbon partial liquid ventilation in a large animal model of acute respiratory failure." Order ALL the reference details at left...
3.	Syndrome 09/12/1996 - "Whether partial liquid ventilation is effective in the treatment of infants with severe respiratory distress syndrome is not known" 01/01/2004 - "Uncontrolled studies in adults have shown improvement in gas exchange and lung compliance with partial liquid ventilation A single uncontrolled study in six children with acute respiratory syndrome showed some improvement in gas exchange during three hours of partial liquid ventilation" 06/01/2004 - "This article is a review of the research findings on the subject of liquid ventilation and how it has shown to improve lung function in patients with respiratory distress syndrome" 03/01/1997 - "Replacing gas in the lung with perfluorocarbon fluids (PFC) and periodically ventilating with a gas [partial liquid ventilation (PLV)] has been shown to improve oxygenation in models of respiratory distress syndrome" 09/01/1993 - "OBJECTIVE: To determine the efficacy of perfluorocarbon-associated gas exchange (partial liquid ventilation) in respiratory distress syndrome" Order ALL the reference details at left...
4.	Lung Diseases (Lung Disease) 12/01/2003 - "Partial liquid ventilation (PLV) has been shown to improve gas exchange in subjects with severe alveolar lung disease" 04/01/2001 - "Partial liquid ventilation (PLV) has been shown to improve gas exchange in paralyzed animals and humans with lung disease" 03/01/2000 - "Partial liquid ventilation (PLV) has been shown to improve gas exchange in paralyzed animals and in humans with lung disease" 10/01/2001 - "Research with liquid ventilation indicates that this technology may benefit patients with acute lung diseases such as ARDS" 09/01/1999 - "CONCLUSION: Partial liquid ventilation is an effective method for controlling ARDS in certain groups of patients with severe lung disease" Order ALL the reference details at left...
5.	Heart Arrest (Cardiac Arrest) 07/01/2006 - "METHODS: After exposure to 60 minutes of cardiac arrest and weaning from cardiopulmonary bypass, 12 piglets (4.2 +/- 0.3 kg) were randomly treated with conventional gas ventilation (control group) or total liquid ventilation (study group) for 240 minutes" 01/01/2001 - "CONCLUSIONS: During cardiac arrest, warm lavage liquid ventilation may produce rapid cardiopulmonary rewarming." 06/01/2005 - "The efficacy of partial liquid ventilation in lung protection during hypotension and cardiac arrest: preliminary study of lung transplantation using non-heart-beating donors." 07/01/2008 - "Liquid ventilation with perfluorocarbons facilitates resumption of spontaneous circulation in a swine cardiac arrest model." Order ALL the reference details at left...

Related Drugs and Biologics

1.	perflubron (L 1913)
2.	Fluorocarbons
3.	Pulmonary Surfactants (Pulmonary Surfactant)
4.	Oleic Acid (Oleate)
5.	Gases
6.	perflubronperfluorocytlbromide
7.	perfluorohexane (perflexane)
8.	Anti-Bacterial Agents (Antibiotics)
9.	Oxygen
10.	Nitric Oxide (Nitrogen Monoxide)

Related Therapies and Procedures

1.	Positive-Pressure Respiration (PEEP)
2.	Artificial Respiration (Mechanical Ventilation)
3.	Lung Transplantation
4.	Cardiopulmonary Bypass (Heart-Lung Bypass)
5.	Microbubbles

Best Treatments:
Research Summary Report
on Adult Respiratory Distress Syndrome

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 320 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>